KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

122 hedge funds and large institutions have $561M invested in KalVista Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 13 closing their positions.

Holders
122
Holders Change
+3
Holders Change %
+2.52%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
17
Increased
50
Reduced
32
Closed
13
Calls
$5.82M
Puts
$1.36M
Net Calls
+$4.46M
Net Calls Change
+$4.53M

Top Buyers

1
VPC
1
Vestal Point Capital
New York
$46.3M
2
State Street
2
State Street
Massachusetts
$14.7M
3
WP
3
Woodline Partners
California
$7.04M
4
JFG
4
Jefferies Financial Group
New York
$4.34M
5
EA
5
Emerald Advisers
Pennsylvania
$9.68M

Top Sellers

1
SC
1
Stempoint Capital
New York
$0
2
FTM
2
First Turn Management
California
$4.11M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$16.4M
4
SVCM
4
Saturn V Capital Management
Texas
$6.44M
5
DCM
5
Driehaus Capital Management
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
VA
1
VR Adviser
New York
$72.4M 6,249,731 – –
TCM
2
Tang Capital Management
California
$50M 4,321,547 +102,718 +2%
SCM
3
Suvretta Capital Management
New York
$48.8M 4,212,005 +20,000 +0.5%
VPC
4
Vestal Point Capital
New York
$46.3M 4,000,000 +1,700,000 +74%
FLSM
5
Frazier Life Sciences Management
California
$42.7M 3,687,867 – –
Capital World Investors
6
Capital World Investors
California
$39.1M 3,374,064 +146,444 +5%
BlackRock
7
BlackRock
New York
$35.5M 3,062,319 +117,203 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$24.9M 2,150,527 +159,939 +8%
BC
9
Boxer Capital
California
$18.4M 1,590,000 – –
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$16.4M 1,419,792 -630,208 -31%
GPP
11
Great Point Partners
Connecticut
$15M 1,299,503 -39,065 -3%
State Street
12
State Street
Massachusetts
$14.7M 1,271,609 +515,179 +68%
MB
13
MPM BioImpact
Massachusetts
$10.4M 896,915 +14,978 +2%
EA
14
Emerald Advisers
Pennsylvania
$9.68M 835,988 +192,091 +30%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$9.62M 830,984 +24,713 +3%
DCM
16
DAFNA Capital Management
California
$8.38M 723,678 -83,295 -10%
EMFAT
17
Emerald Mutual Fund Advisers Trust
Pennsylvania
$7.54M 650,980 +121,615 +23%
WP
18
Woodline Partners
California
$7.04M 608,253 +457,791 +304%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$7.03M 607,036 +72,057 +13%
SCM
20
Silverarc Capital Management
Massachusetts
$6.65M 574,558 +13,675 +2%
SVCM
21
Saturn V Capital Management
Texas
$6.44M 556,489 -571,989 -51%
Schroder Investment Management Group
22
Schroder Investment Management Group
United Kingdom
$5.32M 431,232 -36,766 -8%
Northern Trust
23
Northern Trust
Illinois
$4.39M 379,375 +46,680 +14%
JFG
24
Jefferies Financial Group
New York
$4.34M 375,000 +200,000 +114%
FTM
25
First Turn Management
California
$4.11M 355,000 -704,540 -66%
1
2 3 4 5